NS · Healthcare

Centuple Global Ltd (531099)

Pharmaceuticals & Biotechnology

Centuple Global Ltd (531099) is listed on NS in the Healthcare sector. Industry: Pharmaceuticals & Biotechnology. As of 2026-07-10, reported market cap is $220.60M, P/E ratio is 14.49, net margin is 2.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 531099

Market cap

$220.60M

P/E ratio

14.49

Net margin

2.7%

Centuple Global Ltd (531099) — FAQ

What is Centuple Global Ltd's market cap?

Centuple Global Ltd (531099) has a reported market cap of $220.60M (data as of 2026-07-10).

What is 531099's P/E ratio?

The price-to-earnings (P/E) ratio for Centuple Global Ltd (531099) is 14.49 (data as of 2026-07-10).

Does Centuple Global Ltd pay a dividend?

Dividend yield is not available in the current snapshot for Centuple Global Ltd (531099). Check the MyAverix Finance app for the latest dividend data.

What sector is Centuple Global Ltd in?

Centuple Global Ltd (531099) is classified in the Healthcare sector (Pharmaceuticals & Biotechnology industry).

What exchange is 531099 listed on?

531099 is listed on NS.

What is Centuple Global Ltd's net margin?

Centuple Global Ltd (531099) reports a net margin of 2.7% (data as of 2026-07-10).

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

09R (09R) 10X GENOMICS DL -00001 (1KJ) 160 Health International Ltd (2656) 1CM INC. (IQ70) 2cureX AB (2CUREX) 3-D Matrix Ltd (DMTRF) 3D Global Biotech Inc. (6808) 3D Medicines Inc (1244)